Carlsmed, Inc. (CARL) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Carlsmed, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.617 -- 00:00:06.284 Ladies and gentlemen, thank you for standing by, and welcome to the Carls Med Fourth 00:00:06.284 -- 00:00:10.270 Quarter and Full Year 2025 Earnings Conference Call. 00:00:10.270 -- 00:00:13.775 At this time, all participants are in a listen-only mode. 00:00:13.775 -- 00:00:17.301 After the speaker's presentation, there will be a question-and-answer session. 00:00:17.301 -- 00:00:22.649 I would now like to turn the conference over to your first speaker today, Caroline Corner, 00:00:22.649 -- 00:00:27.012 Investor Relations. Please go ahead, Caroline. 00:00:27.858 -- 00:00:32.463 Thank you, operator. Welcome to Carl Smith's fourth quarter and full year 2025 earnings 00:00:32.463 -- 00:00:37.588 call. Joining me on today's call are Mike Cordonier, Chief Executive Officer and Chairman, 00:00:37.588 -- 00:00:40.431 and Leo Greenstein, Chief Financial Officer. 00:00:40.431 -- 00:00:44.075 Before we begin, I would like to caution that comments made during this call will include 00:00:44.075 -- 00:00:47.979 forward-looking statements within the meaning of the Private Securities Litigation Reform 00:00:47.979 -- 00:00:52.724 Act of 1995. All statements made on this call that do not relate to matters of historical 00:00:52.724 -- 00:00:56.529 fact should be considered forward-looking statements including statements regarding the 00:00:56.529 -- 00:01:00.793 market in which Carls Med operates, trends, expectations, and demands for Carls Med's 00:01:00.793 -- 00:01:05.578 products, and Carls Med's expected financial performance and position in the market. 00:01:05.578 -- 00:01:09.242 Any forward-looking statement provided during this call, including projections for future 00:01:09.242 -- 00:01:13.367 performance, is based on management's exp...